Risk-benefit analyses of drugs: Fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole
- 1 September 1987
- journal article
- Published by Springer Nature in Infection
- Vol. 15 (S5) , S236-S240
- https://doi.org/10.1007/bf01643196
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Challenging the cushing syndrome: Multiattribute evaluation of cortisone drugsOrganizational Behavior and Human Performance, 1978
- Double-blind Trial to Compare Ampicillin, Cephalexin, Co-trimoxazole, and Trimethoprim in Treatment of Urinary InfectionBMJ, 1972